PT March 2026

PharmaTimes March edition ponders, wrestles and wonders at the present life sciences zeitgeist – what a time to be alive! As the cover boldly suggests, we are in an era of patient autonomy and, thus, a brave new landscape in which the population expect and deserve access to medicines. Features examine shifting politics, the rise of "super employees," and ongoing innovation. Articles cover GLP-1s, difficult-to-treat cancers, top therapies of 2026, and AI's relentless advance.

PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat cancers, top therapies of 2026, and AI's advance.

March 2026 - PharmaTimes Magazine

Issues

Online Media Hub

PharmaTimes Magazine

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

https://pharmatimes.com/

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

THE WALLS

Pharma’s role when it comes to challenging health taboos